Company profile
Medline Inc.
NASDAQ: MDLN · Healthcare · Medical - Instruments & Supplies
#22 of 1,418 Healthcare companies by revenue57th-percentile growth
EA Score
62CFH 79DQ 35GM —SS 66
v0.1 · 55/100 weight · provisional
↑ workforce scale, market scale · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$30.5B
Rev growth YoY (TTM)
+12.9%
Net income (FY)
$1.2B
Employees
45,000
as of 2026-09-05
Market cap
$30.9B
as of 2026-09-05
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$28.4B$28.4B2025
Net income$1.2B$1.2B2025
Operating income$2.2B$2.2B2025
Total assets$38.5B$38.5B2025
Liabilities$19.2B$19.2B2025
Equity$10.7B$10.7B2025
Revenue trend
FY2025 – FY2025 · USD
FY25
FY25
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Medline Inc.’s revenue?
Medline Inc. booked $28.4B in FY2025 revenue, growing 11% year over year — about the middle of the pack among Healthcare companies we track, at a 4.1% net margin.
Peers · Healthcare
Amgen Inc.87AMedtronic plc84B+Gilead Sciences, Inc.87AStryker Corporation87ADanaher Corporation87ABecton, Dickinson and Company83B+Neighbors
Cook →Key facts
CEOJames Boyle
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersNorthfield, IL
ExchangeNASDAQ: MDLN
Employees45,000
IPO date2025-12-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.